[Significance of preoperative weight loss for perioperative metabolic adaptation and surgical risk in patients with tumors of the upper gastrointestinal tract].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 1569804)

Published in Langenbecks Arch Chir on January 01, 1992

Authors

A Weimann1, H J Meyer, M J Müller, P Stenkhoff, J Miholic, J Jähne, O Selberg, R Pichlmayr

Author Affiliations

1: Klinik für Abdominal- und Transplantationschirurgie, Hannover, BRD.

Articles by these authors

Jasmonic acid is a signal transducer in elicitor-induced plant cell cultures. Proc Natl Acad Sci U S A (1992) 5.86

Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg (1993) 3.45

Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes (Lond) (2006) 3.40

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet (1994) 3.24

Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg (1991) 3.12

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011. Pharmacopsychiatry (2011) 2.91

The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg (1989) 2.71

Vitamin D status and health correlates among German adults. Eur J Clin Nutr (2007) 2.20

Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol (1997) 2.16

ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr (2006) 2.11

Parental overweight, socioeconomic status and high birth weight are the major determinants of overweight and obesity in 5-7 y-old children: baseline data of the Kiel Obesity Prevention Study (KOPS). Int J Obes Relat Metab Disord (2004) 2.08

Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer (1993) 2.01

Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation (1997) 1.90

Benign liver tumors: differential diagnosis and indications for surgery. World J Surg (1997) 1.83

Total hepatectomy and liver transplantation as two-stage procedure. Ann Surg (1993) 1.83

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol (1989) 1.81

Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. J Clin Oncol (1998) 1.77

Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.62

Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine. Pharmacopsychiatry (2003) 1.62

Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. Transplantation (1996) 1.61

White matter lesion severity in male and female patients with Fabry disease. Neurology (2005) 1.61

Cystic enlargement of extrahepatic bile ducts. Surgery (1993) 1.53

Lymphadenectomy in gastric carcinoma. A prospective and prognostic study. Arch Surg (1992) 1.53

Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J Surg (1988) 1.51

Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology (1998) 1.46

Experiences with liver transplantation in Hannover. Hepatology (1984) 1.45

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J Clin Oncol (1989) 1.44

What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer (1997) 1.43

Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression. Clin Chem (1994) 1.43

[Prolonged intensive care stay after abdominal surgery interventions with special reference to quality of life, occupational rehabilitation and economics]. Chirurg (1997) 1.42

[What is the role of nutrition in ulcerative colitis? A contribution to the current status of diet therapy in treatment of inflammatory bowel diseases]. Langenbecks Arch Chir (1995) 1.41

Brain size, body size and longevity. Int J Obes (Lond) (2010) 1.41

ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr (1997) 1.40

Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation (1988) 1.39

Application of adjusted survival curves to renal transplant data. Methods Inf Med (1992) 1.39

[Multivariate analysis of prognostic factors after resection of ductal pancreatic carcinomas]. Langenbecks Arch Chir (1995) 1.38

Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol (1999) 1.38

Determinants and impact of sleep duration in children and adolescents: data of the Kiel Obesity Prevention Study. Eur J Clin Nutr (2008) 1.38

Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Dig Dis Sci (1991) 1.35

New developments in the treatment of gastric carcinoma. Semin Oncol (1990) 1.32

Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: first successful case report. World J Surg (1991) 1.31

Coordinate control of intermediary metabolism in rat liver by the insulin/glucagon ratio during starvation and after glucose refeeding. Regulatory significance of long-chain acyl-CoA and cyclic AMP. Arch Biochem Biophys (1977) 1.30

Signs of hyperacute rejection of liver grafts in rhesus monkeys after donor-specific presensitization. Transplant Proc (1987) 1.30

Management and results of proximal anastomotic leaks in a series of 1114 total gastrectomies for gastric carcinoma. Eur J Surg Oncol (2000) 1.28

Metabolically active components of fat free mass and resting energy expenditure in nonobese adults. Am J Physiol Endocrinol Metab (2000) 1.27

Effect of organ and tissue masses on resting energy expenditure in underweight, normal weight and obese adults. Int J Obes Relat Metab Disord (2004) 1.27

Protein-calorie malnutrition in liver cirrhosis. Clin Investig (1992) 1.26

Long-term results after surgery for acute mesenteric ischemia. Surgery (1997) 1.26

Patterns of donor-type microchimerism after heart transplantation. Lancet (1994) 1.25

Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology (1997) 1.24

Psychopathological predictors of suicide in patients with major depression during a 5-year follow-up. Eur Psychiatry (2001) 1.24

Liver transplantation. Transplant Proc (1987) 1.23

Lignocaine metabolite formation as a measure of pre-transplant liver function. Lancet (1989) 1.23

Results of portal thrombectomy and splanchnic thrombolysis for the surgical management of acute mesentericoportal thrombosis. Br J Surg (1997) 1.22

Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology (1997) 1.21

A new technique of hepatic vein reconstruction in partial liver transplantation. Transpl Int (1988) 1.19

Production of cytokines (TNF-alpha, IL-1-beta) and endothelial cell activation in human liver allograft rejection. Transplantation (1993) 1.19

Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet (1992) 1.17

Long-term experience after ex situ liver surgery. Surgery (2000) 1.16

Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation. Transplantation (1988) 1.16

Nutritional consequences of total gastrectomy: the relationship between mode of reconstruction, postprandial symptoms, and body composition. Surgery (1990) 1.16

CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine. J Clin Pharm Ther (2006) 1.16

Resection of synchronous liver metastases from colorectal cancer. World J Surg (1991) 1.15

Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today (1994) 1.14

Assessment of pretransplant prognosis in patients with cirrhosis. Transplantation (1991) 1.13

Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med (1994) 1.13

Prognostic factors after resection of ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head. Br J Surg (1995) 1.13

Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology (1995) 1.13

Total hepatectomy as temporary approach to acute hepatic or primary graft failure. Transplant Proc (1988) 1.13

Emptying of the gastric substitute after total gastrectomy. Jejunal interposition versus Roux-y esophagojejunostomy. Ann Surg (1989) 1.12

Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch (1997) 1.10

The benefit from whole body acupuncture in major depression. J Affect Disord (2000) 1.10

Reliability and validity of the form 90 interview. Eur Addict Res (2005) 1.10

Social class differences in overweight of prepubertal children in northwest Germany. Int J Obes Relat Metab Disord (2002) 1.10

Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc (1987) 1.10

Liver transplantation for metastatic neuroendocrine tumors. Ann Surg (1997) 1.09

Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. Transplantation (1996) 1.08

Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc (1987) 1.07

Effect of weight loss and regain on adipose tissue distribution, composition of lean mass and resting energy expenditure in young overweight and obese adults. Int J Obes (Lond) (2013) 1.07

Voxel based analyses of diffusion tensor imaging in Fabry disease. J Neurol Neurosurg Psychiatry (2007) 1.06

Prognostic factors in adenocarcinoma of the cardia. Am J Surg (1995) 1.05

Regional enteritis and granulomatous colitis associated with erythrocyte glucose-6-phosphate dehydrogenase deficiency. N Engl J Med (1967) 1.05

Evolving concepts on adjusting human resting energy expenditure measurements for body size. Obes Rev (2012) 1.04

Reliability and validity of the German version of the European Addiction Severity Index (EuropASI). J Stud Alcohol (2000) 1.04

Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function. J Clin Chem Clin Biochem (1987) 1.04

Passenger lymphocytes in human liver allografts and their potential role after transplantation. Transplantation (1993) 1.04

The influence of other diseases upon the outcome of colorectal cancer patients. Aust N Z J Surg (1995) 1.04

Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma. Br J Cancer (1999) 1.02